angiotensin ii has been researched along with spirapril in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Admiraal, PJ; Boomsma, F; Derkx, FH; Man in 't Veld, AJ; Ritsema van Eck, HJ; Schalekamp, MA; van den Meiracker, AH | 1 |
| Ahn, HS; Baum, T; Coleman, W; Nelson, S; Pula, KK; Rivelli, M; Sabin, C; Sybertz, EJ; Tedesco, R; Watkins, RW | 1 |
| de Bruijn, JH; de Leeuw, PW; Guitard, C; Jacobs, MC; Mellein, B; Thien, T; van Es, PN; van Montfrans, GA; Veerman, DP; Vreugdenhil, G | 1 |
| Christensen, P; Feldt-Rasmussen, B; Jensen, T; Nørgaard, K | 1 |
| Higaki, J; Mikami, H; Miyazaki, M; Morishita, R; Nagano, M; Nakamura, F; Ogihara, T; Tomita, N; Zhao, Y | 1 |
| Miyazaki, M; Okunishi, H; Song, K; Takai, S; Tanaka, T | 1 |
| Alenina, N; Bader, M; Becker, M; Gembardt, F; Krause, W; Maul, B; Pankow, K; Siems, WE; Walther, T | 1 |
| Bader, M; Heilig, M; Lidström, J; Marquitz, M; Rimondini, R; Siems, WE; Sommer, WH | 1 |
3 trial(s) available for angiotensin ii and spirapril
| Article | Year |
|---|---|
Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Drug Administration Schedule; Enalapril; Female; Hemodynamics; Humans; Hypertension; Male; Peptidyl-Dipeptidase A; Single-Blind Method; Time Factors | 1992 |
24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic; Peptidyl-Dipeptidase A; Renin | 1994 |
A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension.
Topics: Adult; Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Enalapril; Endothelium, Vascular; Female; Humans; Hypertension; Isradipine; Lipoproteins; Male; Middle Aged; Potassium; Sodium | 1993 |
5 other study(ies) available for angiotensin ii and spirapril
| Article | Year |
|---|---|
Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril).
Topics: Adrenergic Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Enalapril; Female; Hemodynamics; Hydrochlorothiazide; Male; Nephrectomy; Rats; Rats, Inbred SHR; Renin | 1987 |
Discrepancy between renin mRNA and plasma renin level in angiotensin-converting enzyme inhibitor-treated rats.
Topics: Actins; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Enalapril; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; RNA, Messenger | 1993 |
Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice.
Topics: Administration, Oral; Analgesics; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Brain; Enalapril; Imidazoles; Indoles; Losartan; Male; Mice; Naloxone; Pain Measurement; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Tetrazoles | 1996 |
Central angiotensin II controls alcohol consumption via its AT1 receptor.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Brain; Dopamine; Enalapril; Mice; Mice, Inbred C57BL; Rats; Receptor, Angiotensin, Type 1 | 2005 |
Plasticity and impact of the central renin-angiotensin system during development of ethanol dependence.
Topics: Adaptation, Physiological; Alcoholism; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Animals, Genetically Modified; Central Nervous System; Disease Models, Animal; Enalapril; Ethanol; Humans; Neuronal Plasticity; Rats; Rats, Wistar; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Antisense | 2007 |